These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12706708)

  • 1. Analyzing the economic value of the hepatitis B--Haemophilus influenzae type B combination vaccine by reverse engineering a formulary selection algorithm.
    Jacobson SH; Karnani T; Sewell EC
    Vaccine; 2003 May; 21(17-18):2169-77. PubMed ID: 12706708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Reverse engineering" a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines.
    Sewell EC; Jacobson SH; Weniger BG
    Pediatr Infect Dis J; 2001 Nov; 20(11 Suppl):S45-56. PubMed ID: 11704724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
    Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
    Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between pediatric combination vaccines and market effects.
    Behzad B; Jacobson SH; Jokela JA; Sewell EC
    Am J Public Health; 2014 Jun; 104(6):998-1004. PubMed ID: 24825198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering the economic value of two pediatric combination vaccines.
    Jacobson SH; Sewell EC; Karnani T
    Health Care Manag Sci; 2005 Feb; 8(1):29-40. PubMed ID: 15782510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection.
    Weniger BG; Chen RT; Jacobson SH; Sewell EC; Deuson R; Livengood JR; Orenstein WA
    Vaccine; 1998 Nov; 16(19):1885-97. PubMed ID: 9795397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.
    Zhou F; Bisgard KM; Yusuf HR; Deuson RR; Bath SK; Murphy TV
    Pediatrics; 2002 Oct; 110(4):653-61. PubMed ID: 12359777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine. Potential impact of the introduction of Infanrix-Hexa in the French childhood immunisation schedule.
    Fagnani F; Le Fur C; Durand I; Gibergy M
    Eur J Health Econ; 2004 Jun; 5(2):143-9. PubMed ID: 15452751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
    Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
    Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pricing strategies for combination pediatric vaccines and their impact on revenue: Pediarix or Pentacel?
    Robbins MJ; Jacobson SH; Sewell EC
    Health Care Manag Sci; 2010 Mar; 13(1):54-64. PubMed ID: 20402282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China.
    Ning G; Yin Z; Li Y; Wang H; Yang W
    Hum Vaccin Immunother; 2018 Jan; 14(1):36-44. PubMed ID: 29049002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Monte Carlo simulation to determine combination vaccine price distributions for childhood diseases.
    Jacobson SH; Sewell EC
    Health Care Manag Sci; 2002 Apr; 5(2):135-45. PubMed ID: 11993748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).
    Johns TL; Hutter GE
    Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rats in a large West Coast health maintenance organization.
    Davis RL; Coplan P; Mell L; Black S; Shinefield H; Lewis E
    Pediatr Infect Dis J; 2003 Jul; 22(7):657-8. PubMed ID: 12886895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
    Gargano LM; Hajjeh R; Cookson ST
    Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary.
    Behzad B; Jacobson SH; Sewell EC
    Expert Rev Vaccines; 2012 Oct; 11(10):1189-97. PubMed ID: 23176652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety.
    Mallet E; Belohradsky BH; Lagos R; Gothefors L; Camier P; Carrière JP; Kanra G; Hoffenbach A; Langue J; Undreiner F; Roussel F; Reinert P; Flodmark CE; Stojanov S; Liese J; Levine MM; Muñoz A; Schödel F; Hessel L;
    Vaccine; 2004 Mar; 22(11-12):1343-57. PubMed ID: 15063556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.